Literature DB >> 23732753

Evaluation of a new chemiluminescence immunoassay for laboratory diagnosis of syphilis.

A Sampedro-Martinez1, A Padilla-Malo2, C Gomez-Camarasa1, J Rodriguez-Granger3, A Lara-Oya1.   

Abstract

The purpose of this study was to evaluate diagnostic performances of automated chemiluminescence immunoassay (CLIA) in comparison with Treponema pallidum hemagglutination test (TPHA). The specificity of CLIA was 98.9% and 99.6% for TPHA, whereas the sensitivity was 98% and 96%, respectively. Considering the suitability for automation, CLIA may represent a suitable alternative. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody; Chemiluminescence; Syphilis; TPHA

Mesh：

Year:  2013        PMID： 23732753     DOI： 10.1016/j.mimet.2013.05.015

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN： 0167-7012            Impact factor:   2.363


  4 in total

1.  Evaluation of the HISCL Anti-Treponema pallidum Assay as a Screening Test for Syphilis.

Authors:  Jingna An; Qixia Chen; Qianqian Liu; Chenli Rao; Dongdong Li; Tingting Wang; Chuanmin Tao; Lanlan Wang
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

2.  Evaluation of the Vitros Syphilis TPA chemiluminescence immunoassay as a first-line method for reverse syphilis screening.

Authors:  Victoria González; Gema Fernández; Eva Dopico; Nuria Margall; Juliana Esperalba; Carme Muñoz; Elisabeth Castro; Elena Sulleiro; Lurdes Matas
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

3.  Establishment of Magnetic Microparticles-Assisted Time-Resolved Fluoroimmunoassay for Determinating Biomarker Models in Human Serum.

Authors:  Zhi-Qi Ren; Tian-Cai Liu; Si-Hui Zhuang; Guan-Feng Lin; Jing-Yuan Hou; Ying-Song Wu
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

4.  Infectious diseases prevalence, vaccination coverage, and diagnostic challenges in a population of internationally adopted children referred to a Tertiary Care Children's Hospital from 2009 to 2015.

Authors:  Sara Sollai; Francesca Ghetti; Leila Bianchi; Maurizio de Martino; Luisa Galli; Elena Chiappini
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.